Navigation Links
Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008
Date:3/11/2009

New Molecular Tests and Increasing Case Volumes Drive 78 Percent Revenue Growth in the Fourth Quarter of 2008 as Compared to the Prior Year Period

ALISO VIEJO, Calif., March 11 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today reported preliminary financial results for its fourth quarter and year ended December 31, 2008. Financial results included a 78% increase in revenue for the fourth quarter of 2008 versus the fourth quarter of 2007, and a 72% increase in revenue for the year ended December 31, 2008 versus 2007.

Fourth quarter 2008 revenue from continuing operations was $21.9 million, compared to $12.4 million for the same period in 2007, and $19.0 million for the third quarter 2008. Clarient has posted 18 consecutive quarters of sequential revenue growth. Revenue in 2008 was $73.7 million versus $43.0 million in 2007.

Case volume in the fourth quarter increased 39% from the same period in 2007 to 29,845 cases. For the year ended December 31, 2008, testing volume totaled 108,610 cases, up 46% from the same period in 2007, indicating continued success of the Company's new customer acquisition and depth of menu strategies. The Company's client base of oncology and pathology practices in the U.S. increased to approximately 900 active clients at December 31, 2008 from approximately 675 active clients at December 31, 2007.

"Clarient's top-line growth continues to be driven by newer, higher value diagnostic services for a broad range of cancers, coupled with favorable reimbursement rates," said Ron Andrews, Clarient Vice Ch
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
2. Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer
3. Jim Agnello to Resign as Clarient Chief Financial Officer
4. Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
5. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
6. Clarient to Commercialize Novel Breast Cancer Profile
7. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
8. SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results
9. AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results
10. OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
11. Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... The report “Service Quality Management and Telco Customer ... - Global Advancements, Worldwide Forecasts & Analysis (2014-2019)” defines ... forecasting of revenues. , Browse 152 market data ... TOC on “Service Quality Management (SQM) and Telco Customer ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... 2014 GMO corn cases filed across the ... the process of being consolidated in a Kansas federal court ... AG MIR 162 Corn Litigation, MDL No. 2591 in the ... of the Syngenta GMO corn multidistrict litigation (MDL) has been ...
(Date:12/24/2014)... On Friday, December 19, 2014, President ... Continuing Resolution Appropriations Act of 2015, which for the ... funding through the Congressionally Directed Medical Research Programs (CDMRP) ... Association (HA), working in conjunction with its allies on ...
Breaking Biology Technology:Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... biologics ... cancer, CAMBRIDGE, Mass., June 10 Merrimack Pharmaceuticals,Inc., a ... for autoimmune disease and cancer, today announced that it,has raised ... Existing and new investors participated in the financing including,Credit Suisse ...
... BHRT ) today announced that it has received ... the Nasdaq Capital Market. The Company,s,common stock will be ... Market at the opening of business on Wednesday, June ... the Nasdaq Stock Market for,companies with a lower market ...
... June 10 Miltenyi Biotec has,acquired Medic Tools ... strengthens the portfolio in the area of sample,preparation. ... into the product range of instruments, reagents, and ... Boris Stoffel and,Franz G. Bucher, Vice President and ...
Cached Biology Technology:Merrimack Pharmaceuticals Raises $60 Million in Private Financing 2Bioheart, Inc. to Transfer to Nasdaq Capital Market 2Miltenyi Biotec GmbH Acquires Medic Tools AG 2
(Date:12/19/2014)... DUBLIN , Dec. 18, 2014 Research and Markets ... of the "iPhone 5S Fingerprint Sensor - Apple/AuthenTec ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... 2012, Apple introduced the fingerprint reading feature with the ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM announced ... audit to confirm its adherence to current U.S. Food ... to conduct regulated smart device and smart phone application ... research quality. "HITLAB is determined to improve ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... Environmentalists are just as fond of talking about ... "sustainability" has become a buzzword. The problem is that ... have manifold interpretations. Agricultural scientists at the Technische Universitaet ... colleagues in theoretical and applied science they have managed ...
... viral polymerase may provide a new therapeutic target for host-adapted ... "Spread of Infection and Lymphocyte Depletion in Mice Depends on ... of the American Journal of Pathology . Highly ... strain of the influenza virus that has adapted to infect ...
... An innovative approach to brain research developed by ... School at Houston has been selected for funding ... designed to support high-impact, medical investigations. Valentin ... at the UT Medical School at Houston, has ...
Cached Biology News:New tools for sustainable farming 2New tools for sustainable farming 3UT's Valentin Dragoi gets $1.2 million grant for groundbreaking approach to brain research 2UT's Valentin Dragoi gets $1.2 million grant for groundbreaking approach to brain research 3
The LIC Duet™ Mini Adaptor encodes a T7 promoter, lac operator, ribosome binding site (rbs), and an ATG translation initation codon. This adaptor is designed for expression of a target protei...
... these culture chambers produce cell yields in ... range and are useful alternatives to multiple ... mechanical • strength and structural integrity • ... Certified nonpyrogenic and sterilized by gamma irradiation, ...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
...
Biology Products: